Plus Therapeutics Inc logo

Plus Therapeutics Inc (PSTV)

Market Closed
10 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
5. 39
-0.11
-2%
$
13.31M Market Cap
- P/E Ratio
- Div Yield
123,132 Volume
-2.41 Eps
$ 5.5
Previous Close
Investors:
Add Transaction
Day Range
5.32 5.75
Year Range
2.9 23.5
Want to track PSTV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Plus Therapeutics Inc (PSTV) Statistics

Valuation metrics

Market Cap 13.31M
Enterprise value 10.79M
Trailing P/E (ttm) -3.01
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 2.53
Price/Book (mrq) 3.01
Enterprise Value/Revenue 2.08
Enterprise Value/EBITDA -1.28

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 77.21K
Average volume (90 days) 311.71K

Price summary

52-Week low 2.9
52-Week high 23.5
Beta -
50-Day moving average 6.21
200-Day moving average 8.65

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 2 Apr 2026

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -2.3%
Operating margin -3.64%

Operational effectiveness

Return on assets -0.6%
Return on equity -1.98%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.78
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.8
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.45
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 2.27%
Book value per share (mrq) 1.8

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -